Otrexup

Active Ingredient(s): Methotrexate
FDA Approved: * October 11, 2013
Pharm Company: * ANTARES PHARMA, INC.
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Otrexup Overview

Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.[1] Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, and osteosarcoma.[1] Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's disease.[1] It can ...

Read more Otrexup Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Methotrexate

Recent Otrexup Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Methotrexate
  • Injection: 10 Mg/0.4 Ml, 15 Mg/0.4 Ml, 20 Mg/0.4 Ml And 25mg/0.4 Ml, 1000mg, 100mg/4ml (25mg/ml), 100mg/vial, 10mg/0.20ml, 12.5mg/0.25ml, 15mg/0.30ml, 17.5mg/0.35ml, 1g, 1gm/40ml (25 mg/ml), 1gm/40ml (25mg/ml), 1gm/vial, 2.5gm/100ml (25 mg/ml), 2.5gm/100ml (25mg/ml), 2.5mg/ml, 200mg/8ml (25mg/ml), 20mg, 20mg/0.4ml, 20mg/2ml (10 mg/ml), 20mg/2ml (10mg/ml), 20mg/vial, 22.5mg/0.45ml, 250mg/10ml (25mg/ml), 25mg/0.50ml, 25mg/ml, 27.5mg/0.55ml, 30mg/0.60ml, 500mg/20ml (25 mg/ml), 500mg/20ml (25mg/ml), 50mg/2ml (25 mg/ml), 50mg/2ml (25mg/ml), 50mg/vial, 7.5mg/0.15ml
  • Powder: 100%
  • Solution: 10mg/0.20ml, 10mg/0.20ml (10mg/0.20ml), 10mg/0.4ml, 10mg/0.4ml (10mg/0.4ml), 12.5mg/0.25ml, 12.5mg/0.25ml (12.5mg/0.25ml), 12.5mg/0.4ml (12.5mg/0.4ml), 15mg/0.30ml, 15mg/0.30ml (15mg/0.30ml), 15mg/0.4ml, 15mg/0.4ml (15mg/0.4ml), 15mg/0.6ml (15mg/0.6ml), 17.5mg/0.35ml, 17.5mg/0.35ml (17.5mg/0.35ml), 17.5mg/0.4ml (17.5mg/0.4ml), 17.5mg/0.7ml (17.5mg/0.7ml), 2.5mg/ml, 20mg/0.4ml, 20mg/0.4ml (20mg/0.4ml), 20mg/0.8ml (20mg/0.8ml), 22.5mg/0.45ml, 22.5mg/0.45ml (22.5mg/0.45ml), 22.5mg/0.4ml (22.5mg/0.4ml), 22.5mg/0.9ml (22.5mg/0.9ml), 25mg/0.4ml, 25mg/0.4ml (25mg/0.4ml), 25mg/0.5ml, 25mg/0.5ml (25mg/0.5ml), 25mg/ml (25mg/ml), 27.5mg/0.55ml, 27.5mg/0.55ml (27.5mg/0.55ml), 2mg/ml, 30mg/0.6ml, 30mg/0.6ml (30mg/0.6ml), 7.5mg/0.15ml, 7.5mg/0.15ml (7.5mg/0.15ml), 7.5mg/0.4ml, 7.5mg/0.4ml (7.5mg/0.4ml)
  • Tablet: 10mg, 15mg, 2.5mg, 5mg, 7.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Otrexup: (8 results)

Sorted by National Drug Code
  • 54436-010 Otrexup 10 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.
  • 54436-012 Otrexup 12.5 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.
  • 54436-015 Otrexup 15 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.
  • 54436-017 Otrexup 17.5 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.
  • 54436-020 Otrexup 20 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.
  • 54436-022 Otrexup 22.5 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.
  • 54436-025 Otrexup 25 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.
  • 54436-075 Otrexup 7.5 mg/.4ml Subcutaneous Injection, Solution by Antares Pharma, Inc.

Other drugs which contain Methotrexate or a similar ingredient: (8 results)

Related Otrexup Topics:

otrexup
is any available...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA